UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) September 1, 2013
Alteva, Inc.
(Exact name of registrant as specified in its charter)
New York |
| 1-35724 |
| 14-1160510 |
(State or other jurisdiction |
| (Commission |
| (IRS Employer |
401 Market Street, Philadelphia, PA |
| 19106 |
(Address of principal executive offices) |
| (Zip Code) |
Registrant’s telephone number, including area code 877-258-3722
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01 Other Events.
On September 4, 2013, Alteva, Inc. announced that it had entered into an agreement to sell substantially all of the USA Datanet related assets of its wholly owned subsidiary Alteva of Syracuse, Inc. to a third party for approximately $600,000. A copy of the press release announcing the transaction is attached hereto as Exhibit No. 99.1.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits.
Exhibit No. |
| Description |
99.1 |
| Press Release issued by Alteva, Inc. on September 4, 2013. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Alteva, Inc. | |
|
| |
|
| |
Date: September 4, 2013 | By: | /s/ David J. Cuthbert |
|
| David J. Cuthbert |
|
| President and Chief Executive Officer |